<DOC>
	<DOCNO>NCT01690260</DOCNO>
	<brief_summary>Results growth factor indicate Bone Morphogenetic Proteins ( BMP ) exceptional ability stimulate different characteristic mesenchymale cell osseous cell . Local application BMP result increase osseous tissue regardless location growth factor . 5 year clinical study show BMP 's stimulate increase osseous tissue improve clinical result autologous bone graft reduce remove . The purpose study examine whether recombinant growth factor BMP-2 replace autologous bone graft order stimulate ossification transplantation osseous tissue .</brief_summary>
	<brief_title>Parallel Study Between BMP-2 Autologous Bone Graft After Ilizarow Treatment</brief_title>
	<detailed_description />
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Bone Diseases</mesh_term>
	<criteria>Hospitalised autologous bone graft base Ilizarow treatment . Age 20 70 year . Rheumatoid osteoarthritis Malignant disease Current hormone treatment ( glucocorticoid , parathyreoidea , thyreoidea ) Pregnancy Abuse drug alcohol Need longterm NSAID treatment Breastfeeding woman</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>Bone</keyword>
	<keyword>Morphogenetic</keyword>
	<keyword>Protein</keyword>
	<keyword>Ilizarow</keyword>
	<keyword>Autologous</keyword>
	<keyword>Osteoarthritis</keyword>
</DOC>